PROC Procaps
- 1.830
- -0.070-3.68%
Procaps News
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hoche Partners Pharma Holding S.A.(14.1%)
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hoche Partners Pharma Holding S.A.(14.1%)
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hoche Partners Pharma Holding S.A.(14.1%)
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hoche Partners Pharma Holding S.A.(14.1%)
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hoche Partners Pharma Holding S.A.(14.1%)
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Report of foreign private issuer (related to financial reporting)
6-K: Report of foreign private issuer (related to financial reporting)
NT 20-F: Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F
Procaps | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Procaps | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hoche Partners Pharma Holding S.A.(14.1%)
Procaps | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Procaps | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Procaps | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Hoche Partners Pharma Holding S.A.(14.1%)
Procaps | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Procaps | 6-K: Report of foreign private issuer (related to financial reporting)
Analysis
Price Target
No Data
